메뉴 건너뛰기




Volumn 298, Issue 21, 2007, Pages 2545-

New weapons needed to fight HIV: A call for papers

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

EID: 36849089637     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.21.2545     Document Type: Editorial
Times cited : (1)

References (11)
  • 1
    • 0029682156 scopus 로고    scopus 로고
    • AIDS in 1996: Much accomplished, much to do
    • Fauci AS. AIDS in 1996: much accomplished, much to do. JAMA. 1996;276(2):155-156.
    • (1996) JAMA , vol.276 , Issue.2 , pp. 155-156
    • Fauci, A.S.1
  • 2
    • 36849052886 scopus 로고    scopus 로고
    • Posted August 6, 2007
    • FDA approves novel antiretroviral drug [press release, FDA Web site, November 11
    • FDA approves novel antiretroviral drug [press release]. FDA Web site. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01677.html. Posted August 6, 2007. Accessed November 11, 2007.
    • (2007) Accessed
  • 3
    • 36849034881 scopus 로고    scopus 로고
    • FDA approves first drug in new class of HIV treatments for HIV infected adults and children with advanced disease [press release, FDA Web site, Posted March 13, 2003. Accessed November 11, 2007
    • FDA approves first drug in new class of HIV treatments for HIV infected adults and children with advanced disease [press release]. FDA Web site. http://www.fda.gov/bbs/topics/NEWS/2003/NEW00879.html. Posted March 13, 2003. Accessed November 11, 2007.
  • 4
    • 36849080797 scopus 로고    scopus 로고
    • FDA approves new HIV drug: raltegravir tablets used in combination with other antiretroviral agents [press release]. FDA Web site. http://www.fda.gov/ bbs/topics/NEWS/2007/NEW01726.html. Posted October 16, 2007. Accessed November 11, 2007.
    • FDA approves new HIV drug: raltegravir tablets used in combination with other antiretroviral agents [press release]. FDA Web site. http://www.fda.gov/ bbs/topics/NEWS/2007/NEW01726.html. Posted October 16, 2007. Accessed November 11, 2007.
  • 5
    • 35448950466 scopus 로고    scopus 로고
    • Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia
    • Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298(16):1888-1899.
    • (2007) JAMA , vol.298 , Issue.16 , pp. 1888-1899
    • Bolton-Moore, C.1    Mubiana-Mbewe, M.2    Cantrell, R.A.3
  • 6
    • 36849023050 scopus 로고    scopus 로고
    • Bringing HIV prevention to scale: an urgent global priority. Global HIV Prevention Working Group. June 2007. http://www.iasociety.org/web/webcontent/ file/pwg-hiv_prevention_report_final.pdf. Posted June 2007. Accessed November 11, 2007.
    • Bringing HIV prevention to scale: an urgent global priority. Global HIV Prevention Working Group. June 2007. http://www.iasociety.org/web/webcontent/ file/pwg-hiv_prevention_report_final.pdf. Posted June 2007. Accessed November 11, 2007.
  • 7
    • 36849080293 scopus 로고    scopus 로고
    • Advancing HIV prevention: new strategies for a changing epidemic. CDC Web site. http://www.cdc.gov/hiv/topics/prev_prog/AHP/default.htm. Updated March 2007. Accessed November 11, 2007.
    • Advancing HIV prevention: new strategies for a changing epidemic. CDC Web site. http://www.cdc.gov/hiv/topics/prev_prog/AHP/default.htm. Updated March 2007. Accessed November 11, 2007.
  • 8
    • 26444620820 scopus 로고    scopus 로고
    • Accessed November 11, 2007
    • Global summary of the AIDS epidemic. December 2006. http://data.unaids. org/pub/epireport/2006/02-global_summary_2006_epiupdate_eng.pdf. Accessed November 11, 2007.
    • Global summary of the AIDS epidemic. December 2006
  • 9
    • 36849023335 scopus 로고    scopus 로고
    • Vaccination and enrollment are discontinued in phase II trials of Merck's investigational HIV vaccine candidate. Merck Web site. http://www.merck.com/ newsroom/press_releases/research_and_development/2007_0921.html. Posted September 21, 2007. Accessed November 11, 2007.
    • Vaccination and enrollment are discontinued in phase II trials of Merck's investigational HIV vaccine candidate. Merck Web site. http://www.merck.com/ newsroom/press_releases/research_and_development/2007_0921.html. Posted September 21, 2007. Accessed November 11, 2007.
  • 10
    • 36849027165 scopus 로고    scopus 로고
    • International AIDS Society Web site, Accessed November 11, 2007
    • International AIDS Society Web site. http://www.aids2008.org/. Accessed November 11, 2007.
  • 11
    • 84872496805 scopus 로고    scopus 로고
    • Accessed November 11
    • JAMA Instructions for Authors. http://jama.ama-assn.org/misc/ ifora.dtl. Accessed November 11, 2007.
    • (2007) Instructions for Authors
    • JAMA1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.